THE SCHEDULE 13G

Company

TENAX THERAPEUTICS, INC.

Filed

August 19, 2024

Accession Number

0000921895-24-001868

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →